Omada Health, Inc.
OMDA
$12.61
$0.040.32%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Net Income | 162.53% | 65.55% | 50.33% | 50.19% | |
| Total Depreciation and Amortization | -2.10% | 1.74% | 15.46% | 18.49% | |
| Total Amortization of Deferred Charges | 3.81% | 18.71% | 21.40% | 40.03% | |
| Total Other Non-Cash Items | -2.26% | 288.38% | 64.80% | 16.80% | |
| Change in Net Operating Assets | 355.40% | -32.68% | 241.46% | -86.48% | |
| Cash from Operations | 429.57% | 859.56% | 135.28% | 21.94% | |
| Capital Expenditure | -8.15% | -606.58% | -78.29% | -71.20% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -46.11% | -46.17% | -9.63% | -56.45% | |
| Cash from Investing | -38.91% | -86.05% | -19.62% | -59.92% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 162.85% | 213.06% | 41,721.23% | -6.98% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | 100.09% | -247.43% | 25.20% | -26.62% | |
| Cash from Financing | 2,887.61% | -7,604.01% | 11,251.38% | -33.09% | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 418.79% | -5,523.62% | 1,644.80% | 18.58% | |